» Articles » PMID: 40018380

In-silico Development of a Novel TLR2-mediating Multi-epitope Vaccine Against

Overview
Date 2025 Feb 28
PMID 40018380
Authors
Affiliations
Soon will be listed here.
Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-025-00322-8.

References
1.
Glover R, Kriakov J, Garforth S, Baughn A, Jacobs Jr W . The two-component regulatory system senX3-regX3 regulates phosphate-dependent gene expression in Mycobacterium smegmatis. J Bacteriol. 2007; 189(15):5495-503. PMC: 1951828. DOI: 10.1128/JB.00190-07. View

2.
Madan R, Pandit K, Bhati L, Kumar H, Kumari N, Singh S . Mining the Mycobacterium tuberculosis proteome for identification of potential T-cell epitope based vaccine candidates. Microb Pathog. 2021; 157:104996. DOI: 10.1016/j.micpath.2021.104996. View

3.
Smith I . Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev. 2003; 16(3):463-96. PMC: 164219. DOI: 10.1128/CMR.16.3.463-496.2003. View

4.
Chakaya J, Petersen E, Nantanda R, Mungai B, Migliori G, Amanullah F . The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB. Int J Infect Dis. 2022; 124 Suppl 1:S26-S29. PMC: 8934249. DOI: 10.1016/j.ijid.2022.03.011. View

5.
Heo L, Park H, Seok C . GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Res. 2013; 41(Web Server issue):W384-8. PMC: 3692086. DOI: 10.1093/nar/gkt458. View